Rekha Jhunjhunwala-Backed IKS Health Share Price Ends With 53% Listing Day Gains
IKS Health share price surged 6.84% on NSE and 5.62% on BSE intraday.
Shares of Rekha Jhunjhunwala-backed Inventurus Knowledge Solutions Ltd. closed on the National Stock Exchange on Friday at Rs 2030 apiece, 52.75% over the issue price of Rs 1,329. On the BSE, the stock closed at 1,960.25, with a listing day gain of 47.50%.
Shares of the healthcare company surged 6.84% on NSE and 5.62% on BSE intraday.
The stock debuted on the National Stock Exchange at Rs 1,900 apiece, at a premium of 42.96% over issue price of Rs 1,329. The stock listed on the BSE at Rs 1,856 per share, marking a premium of 39.65%.
The book building offer was subscribed 52.68 times on its final day of bidding, with bids led by qualified institutional buyers and non-institutional investors. The company allotted 84.2 lakh shares at Rs 1,329 apiece to 61 anchor investors, with domestic mutual funds securing 33.33% of the total allocation through 12 funds across 23 schemes.
ICICI Securities Ltd., Jefferies India Pvt., JM Financial Ltd., JPMorgan India Pvt., and Nomura Financial Advisory And Securities (India) Pvt. were the book running lead managers of the Inventurus IPO. Link Intime India Pvt. was the registrar for the issue.
Inventurus Knowledge Solutions Business
Inventurus Knowledge Solutions, a Navi Mumbai-based technology-enabled healthcare solutions provider, specialises in delivering a care enablement platform for physician enterprises across the US, Canada, and Australia, with a primary focus on the US market.
The firm's platform supports outpatient and inpatient care organisations in delivering clinical care, improving population health outcomes, and transitioning to the "fee for value" model. By partnering with healthcare organisations, Inventurus Knowledge Solutions helps optimise revenue, reduce operational costs, and drive efficiency in healthcare delivery.
The IPO is backed by Rekha Jhunjhunwala and RARE Enterprises. Rekha, who inherited a prominent stock portfolio from her late husband Rakesh Jhunjhunwala, has continued his legacy of significant investments in promising companies. The company filed its preliminary IPO papers in August and received approval from the markets regulator between Nov. 4 and Nov. 8.
